|
(Health-NewsWire.Net, October 27, 2021 ) Hemostasis-Coagulation Analysis Market size is estimated to reach $5.3 billion by 2026, growing at a CAGR of 9.6% during the forecast period 2021-2026. Hemostasis-Coagulation Analysis provides easy process measurement of blood platelet levels and evaluates the velocity of various concentrations in a short time. Hemostasis-Coagulation analyzers are increasingly being adopted to enhance the quality of life of patients suffering from thrombotic and bleeding disorders and to aid in the diagnosis and monitoring of thrombotic thrombocytopenic purpura (TTP). The rise in the availability of advanced hemostasis-coagulation analyzers in hospitals, growing adoption of activated partial thromboplastin time (APTT) tests for detecting coagulation inhibitors, increase in the prevalence of bleeding disorders and lifestyle associated diseases, and growing investment by the key players to develop advanced hemostasis-coagulation analyzers are the factors that are set to drive the growth of the Hemostasis-Coagulation Analysis Market for the period 2021-2026.
Hemostasis-Coagulation Analysis Market Segment Analysis-By Test Type
The Hemostasis-Coagulation Analysis Market based on the Test Type can be further segmented into Activated Partial Thromboplastin Time (APTT), D-Dimer, Fibrinogen, Prothrombin Time (PT) Test, Platelet Function, and Others. The Prothrombin Time (PT) Test segment held the largest share in 2020 and is also estimated to be the fastest-growing segment with a CAGR of 10.8% over the period 2021-2026. This growth is owing to the factors such as the increase in the commercial availability of analyzers to aid in the diagnosis and monitoring of thrombotic thrombocytopenic purpura (TTP) and the rise in awareness about prothrombin time (PT) tests. The growing demand for advanced analyzers to produce results in less time is driving the growth of the Hemostasis-Coagulation Analysis Market. The Activated Partial Thromboplastin Time (APTT) segment held the second-largest share in 2020 owing to the factors such as the growing adoption of activated partial thromboplastin time (APTT) tests for detecting coagulation inhibitors and the rise in the demand for APTT tests in clinical laboratories.
Request for Sample Report @ https://www.industryarc.com/pdfdownload.php?id=501258
Report Price: $ 4500 (Single User License)
Hemostasis-Coagulation Analysis Market Segment Analysis-By End User
The Hemostasis-Coagulation Analysis Market based on the End User can be further segmented into Hospitals, Research Institutes, Clinical Laboratories, and Others. The Hospitals segment held the largest share in 2020 owing to the factors such as the increase in the prevalence of thrombotic thrombocytopenic purpura (TTP) and the rise in the availability of advanced hemostasis-coagulation analyzers in hospitals. The rise in the demand for prothrombin time (PT) tests in hospitals is driving the growth of the Hemostasis-Coagulation Analysis Market. The Clinical Laboratories segment is estimated to be the fastest-growing segment with a CAGR of 10.5% over the period 2021-2026. This growth is owing to the factors such as the rise in the volume of coagulation testing in clinical laboratories and the growing awareness among the patients about the availability of various tests in clinical laboratories.
Hemostasis-Coagulation Analysis Market Segment Analysis-By Geography
North America held the largest share with 29% of the overall market in 2020. The growth in this segment is owing to the factors such as the growing prevalence of bleeding disorders and lifestyle-associated diseases and the rise in the availability of advanced hemostasis-coagulation analyzers in hospitals. The increasing demand for clinical laboratory analyzers and point-of-care testing analyzers to enhance the quality of life of patients is driving the growth of the Hemostasis-Coagulation Analysis Market. Asia-Pacific segment is estimated to be the fastest-growing segment over the period 2021-2026. The growth in this segment is owing to the factors such as the rise in the adoption of APTT tests for detecting coagulation inhibitors and the growing investment by the key players to develop advanced hemostasis-coagulation analyzers.
Inquiry Before Buying @ https://www.industryarc.com/reports/request-quote?id=501258
Hemostasis-Coagulation Analysis Market Drivers
Rise in the Prevalence of Lifestyle-Associated Diseases.
Hemostasis-coagulation analyzers are increasingly being adopted across the world owing to the growing incidences of hemorrhage and various lifestyle-associated diseases. Governments of various nations are also providing funds to develop hemostasis-coagulation analyzers for the treatment of these diseases, which is one of the major factors driving the growth of the Hemostasis-Coagulation Analysis Market.
Technological Advancements in Hemostasis-Coagulation Analysers.
The key players are focusing on developing advanced clinical laboratory analyzers and point-of-care testing analyzers owing to enhance the quality of life of patients suffering from thrombotic and bleeding disorders. The growing demand for accurate results in less time has propelled the demand for advanced analyzers, which is further propelling the growth of the Hemostasis-Coagulation Analysis Market.
Hemostasis-Coagulation Analysis Market Challenges
High Cost of Automated Hemostasis-Coagulation Analysers.
The key players in the market are collaborating with other players to carry out various research and development activities for launching advanced hemostasis-coagulation analyzers for the treatment of various bleeding disorders. However, the high cost of automated hemostasis-coagulation analyzers is one of the major factors that is estimated to reduce the growth of the Hemostasis-Coagulation Analysis Market.
Hemostasis-Coagulation Analysis Market Competitive Landscape:
Product launches, mergers and acquisitions, joint ventures, and geographical expansions are key strategies adopted by players in the Hemostasis-Coagulation Analysis Market. Key companies of this market are Abbott Laboratories, Danaher, Sysmex Group, Thermo Fisher Scientific, Nihon Kohden, Bio Group Medical System, Genrui Biotech Inc, Instrumentation Laboratory, Helena Laboratories, and Siemens Healthineers Group among others.
Acquisitions/Product Launches:
In December 2020, Nihon Kohden has launched an Automated Hematology Coagulation and ESR Analyzer to measure complete blood count and erythrocyte sedimentation rate simultaneously and to provide test results for understanding the clinical condition of patients.
In July 2020, Sysmex has launched next-generation automated hemostasis coagulation analyzers CN-3000 and CN-6000 to enhance the quality of life of patients suffering from thrombotic and bleeding disorders and to increase the number of tests performed for therapy monitoring and diagnoses.
In September 2019, Instrumentation Laboratory has launched the HemosIL AcuStar ADAMTS13 Activity Analyzer to aid in the diagnosis and monitoring of Thrombotic Thrombocytopenic Purpura (TTP) to produce results in approximately 30 minutes.
Key Takeaways
Geographically, North America Hemostasis-Coagulation Analysis Market accounted for the highest revenue share in 2020 and it is poised to dominate over the period 2021-2026 owing to the growing demand for clinical laboratory analyzers and point-of-care testing analyzers to enhance the quality of life of patients.
The increase in the commercial availability of analyzers to aid in the diagnosis and monitoring of thrombotic thrombocytopenic purpura (TTP) is driving the Prothrombin Time (PT) Test segment. However, the high cost of automated hemostasis-coagulation analyzers is one of the major factors that is said to reduce the growth of the Hemostasis-Coagulation Analysis Market.
Detailed analysis on the Strength, Weakness, and Opportunities of the prominent players operating in the market will be provided in the Hemostasis-Coagulation Analysis Market report.
Relevant Reports:
A. Hemostasis Products Market
https://www.industryarc.com/Report/16948/hemostasis-products-market.html
B. Hemostatic Agents Market
https://www.industryarc.com/Report/15189/hemostats-market.html
For more Lifesciences and Healthcare related reports, please click here
About IndustryARC: IndustryARC primarily focuses on Cutting Edge Technologies and Newer Applications market research. Our Custom Research Services are designed to provide insights on the constant flux in the global supply-demand gap of markets. Our strong team of analysts enables us to meet the client research needs at a rapid speed, with a variety of options for your business. Any other custom requirements can be discussed with our team, drop an e-mail to sales@industryarc.com to discuss more about our consulting services.
IndustryARC
Venkat Reddy
(+1) 970-236-3677
venkat@industryarc.com
Source: EmailWire.Com 
|
